MPD: Phenotype strain survey measures: glucose

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Attie2:11	Attie2	None	(none)	date of oral glucose tolerance test date_oGTT 110628 categorical informational	DO population		both		N=248	2018

Attie2:76	Attie2	metabolic panel	high-fat high-sucrose diet	plasma glucose after diet (4h fast) [mg/dL] GLU 110693 wk: 6 10 14 22	DO population		both	10-26wks	N=250	2018

Attie2:88	Attie2	body weight	high-fat high-sucrose diet	body weight at time of oral glucose tolerance test (~14 wks on diet) [g] bw_oGTT 110705	DO population		both	18wks	N=248	2018

Attie2:89	Attie2	glucose tolerance	high-fat high-sucrose diet	glucose level at t=0 after ~14 wks on diet (4h fast) [mg/dL] GLU_0min 110706	DO population		both	18wks	N=248	2018

Attie2:90	Attie2	glucose tolerance	high-fat high-sucrose diet	insulin level at t=0 after ~14 wks on diet (4h fast) [ng/mL] INS_0min 110707	DO population		both	18wks	N=248	2018

Attie2:91	Attie2	glucose tolerance	high-fat high-sucrose diet	HOMA-IR: (glucose x insulin) / 405 at t=0 after ~14 wks on diet (4h fast) HOMA_IR 110708	DO population		both	18wks	N=248	2018

Attie2:92	Attie2	glucose tolerance	high-fat high-sucrose diet	HOMA-B: (360 x insulin) / (glucose minus 63) at t=0 after ~14 wks on diet (4h fast) HOMA_B 110709	DO population		both	18wks	N=246	2018

Attie2:93	Attie2	glucose tolerance	high-fat high-sucrose diet	glucose area under curve (AUC) after ~14 wks on diet without correction for baseline difference (4h fast) [AUC] GLU_AUC_tot 110710	DO population		both	18wks	N=248	2018

Attie2:94	Attie2	glucose tolerance	high-fat high-sucrose diet	glucose area under curve (AUC) after ~14 wks on diet after subtraction of glucose at t=0 (4h fast) [AUC] GLU_AUC_adj 110711	DO population		both	18wks	N=248	2018

Attie2:95	Attie2	glucose tolerance	high-fat high-sucrose diet	insulin area under curve (AUC) after ~14 wks on diet without correction for baseline difference (4h fast) [AUC] INS_AUC_tot 110712	DO population		both	18wks	N=248	2018

Attie2:96	Attie2	glucose tolerance	high-fat high-sucrose diet	insulin area under curve (AUC) after ~14 wks on diet after subtraction of insulin at t=0 (4h fast) [AUC] INS_AUC_adj 110713	DO population		both	18wks	N=248	2018

Attie2:97	Attie2	hormone quantification	high-fat high-sucrose diet	plasma adiponectin measured at the time oral glucose tolerance test performed after ~14 wks on diet (4h fast) [µg/mL] adiponectin 110714	DO population		both	18wks	N=144	2018

Attie2:98	Attie2	hormone quantification	high-fat high-sucrose diet	plasma leptin measured at the time oral glucose tolerance test performed after ~14 wks on diet (4h fast) [ng/mL] leptin 110715	DO population		both	18wks	N=96	2018

Attie2:102	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to glucose [ng/mL] INS_GLU 110719 3.3 mM 8.3 mM 16.7 mM	DO population		both	19-26wks	N=242	2018

Attie2:105	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl [ng/mL] INS_GLU3p3_KCl 110722	DO population		both	19-26wks	N=240	2018

Attie2:106	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1 [ng/mL] INS_GLU8p3_GLP1 110723	DO population		both	19-26wks	N=240	2018

Attie2:107	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu) [ng/mL] INS_GLU8p3_AA 110724	DO population		both	19-26wks	N=240	2018

Attie2:108	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid [ng/mL] INS_GLU16p7_PA 110725	DO population		both	19-26wks	N=240	2018

Attie2:109	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_fc_G3p3 110726	DO population		both	19-26wks	N=240	2018

Attie2:110	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose, expressed as fold-change over that observed with 3.3.mM glucose [ratio] INS_GLU16p7_fc_G3p3 110727	DO population		both	19-26wks	N=240	2018

Attie2:111	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU3p3__KCl_fc_G3p3 110728	DO population		both	19-26wks	N=240	2018

Attie2:112	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G3p3 110729	DO population		both	19-26wks	N=240	2018

Attie2:113	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G3p3 110730	DO population		both	19-26wks	N=240	2018

Attie2:114	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus palmitic acid, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU16p7_PA_fc_G3p3 110731	DO population		both	19-26wks	N=240	2018

Attie2:115	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G8p3 110732	DO population		both	19-26wks	N=240	2018

Attie2:116	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G8p3 110733	DO population		both	19-26wks	N=240	2018

Attie2:117	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as fold-change over that observed with 16.7 mM glucose [ratio] INS_GLU16p7_PA_fc_G16p7 110734	DO population		both	19-26wks	N=240	2018

Attie2:118	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to glucose, expressed as a percentage of total insulin per mouse [%] INS_pct_GLU 110735 3.3 mM 8.3 mM 16.7 mM	DO population		both	19-26wks	N=241	2018

Attie2:121	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as a percentage of total insulin per mouse [%] INS_GLU3p3_KCl_pct 110738	DO population		both	19-26wks	N=239	2018

Attie2:122	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as a percentage of total insulin per mouse [%] INS_GLU8p3_GLP1_pct 110739	DO population		both	19-26wks	N=239	2018

Attie2:123	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as a percentage of total insulin per mouse [%] INS_GLU8p3_AA_pct 110740	DO population		both	19-26wks	N=239	2018

Attie2:124	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as a percentage of total insulin per mouse [%] INS_GLU16p7_PA_pct 110741	DO population		both	19-26wks	N=239	2018

Attie2:125	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to glucose (geometric mean) [ng/mL] INS_gm_GLU 110742 3.3 mM 8.3 mM 16.7 mM	DO population		both	19-26wks	N=242	2018

Attie2:128	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl (geometric mean) [ng/mL] INS_gm_GLU3p3_KCl 110745	DO population		both	19-26wks	N=240	2018

Attie2:129	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1 (geometric mean) [ng/mL] INS_gm_GLU8p3_GLP1 110746	DO population		both	19-26wks	N=240	2018

Attie2:130	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu) (geometric mean) [ng/mL] INS_gm_GLU8p3_AA 110747	DO population		both	19-26wks	N=240	2018

Attie2:131	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid (geometric mean) [ng/mL] INS_gm_GLU16p7_PA 110748	DO population		both	19-26wks	N=240	2018

Attie2:133	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo glucagon secretion after diet in response to 3.3 mM glucose plus 40 mM KCl [ng/mL] GCG_GLU3p3_KCl 110750	DO population		both	19-26wks	N=182	2018

Attie2:134	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo glucagon secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as a percentage of total glucagon per mouse [%] GCG_GLU3p3_KCl_pct 110751	DO population		both	19-26wks	N=182	2018

Auwerx1:63	Auwerx1	body weight	high-fat diet	body weight prior to oral glucose tolerance test (OGTT), 17 wks of age [g] bw_ogtt 111242 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:65	Auwerx1	glucose tolerance	high-fat diet	glucose baseline, glucose tolerance test (pregavage, overnight fast) [mg/dL] ogtt_gluc_t0 111244 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:67	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [mg/dL] ogtt_gluc_t15 111246 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:69	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [mg/dL] ogtt_gluc_t30 111248 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:71	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 45 min [mg/dL] ogtt_gluc_t45 111250 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:73	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 60 min [mg/dL] ogtt_gluc_t60 111252 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:75	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 90 min [mg/dL] ogtt_gluc_t90 111254 CD HFD	BXD w/par	55	m	17wks	N=4	2016

Auwerx1:77	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 120 min [mg/dL] ogtt_gluc_t120 111256 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:79	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 150 min [mg/dL] ogtt_gluc_t150 111258 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:81	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 180 min [mg/dL] ogtt_gluc_t180 111260 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:83	Auwerx1	glucose tolerance	high-fat diet	glucose, area under curve, glucose tolerance test (20% glucose oral gavage, overnight fast) [AUC] ogtt_gluc_auc 111262 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:85	Auwerx1	hormone quantification	high-fat diet	insulin baseline, glucose tolerance test (pregavage, overnight fast) [µg/L] ogtt_ins_t0 111264 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:87	Auwerx1	hormone quantification	high-fat diet	insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [µg/L] ogtt_ins_t15 111266 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:89	Auwerx1	hormone quantification	high-fat diet	insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [µg/L] ogtt_ins_t30 111268 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:91	Auwerx1	hormone quantification	high-fat diet	insulin, area under curve, glucose tolerance test (20% glucose oral gavage, overnight fast) [AUC] ogtt_ins_auc 111270 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:177	Auwerx1	metabolic panel	high-fat diet	blood glucose amount [mmol/L] glu 111356 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx2:53	Auwerx2	body weight	(none)	body weight loss following 16h fast, prior to oral glucose tolerance test (OGTT), 16 wks of age [g] bw_16wks_ogtt 114581 CD HFD	inbred w/CC8	9	both	16wks	N=4	2021

Auwerx2:55	Auwerx2	glucose tolerance	(none)	glucose baseline, glucose tolerance test (pregavage, overnight fast) [mg/dL] ogtt_gluc_t0 114583 CD HFD	inbred w/CC8	9	both	16wks	N=4	2021

Auwerx2:57	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [mg/dL] ogtt_gluc_t15 114585 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:59	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [mg/dL] ogtt_gluc_t30 114587 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:61	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 45 min [mg/dL] ogtt_gluc_t45 114589 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:63	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 60 min [mg/dL] ogtt_gluc_t60 114591 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:65	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 90 min [mg/dL] ogtt_gluc_t90 114593 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:67	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 120 min [mg/dL] ogtt_gluc_t120 114595 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:69	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 150 min [mg/dL] ogtt_gluc_t150 114597 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:71	Auwerx2	glucose tolerance	(none)	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 180 min [mg/dL] ogtt_gluc_t180 114599 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:73	Auwerx2	hormone quantification	(none)	insulin baseline, glucose tolerance test (pregavage, overnight fast) [µg/L] ogtt_ins_t0 114601 CD HFD	inbred w/CC8	9	both	16wks	N=4	2021

Auwerx2:75	Auwerx2	hormone quantification	(none)	insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [µg/L] ogtt_ins_t15 114603 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Auwerx2:77	Auwerx2	hormone quantification	(none)	insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [µg/L] ogtt_ins_t30 114605 CD HFD	inbred w/CC8	8	both	16wks	N=4	2021

Bennett4:51	Bennett4	metabolic panel	various diets 2	plasma glucose amount, baseline [mg/dL] GLU_base 114745 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:53	Bennett4	metabolic panel	various diets 2	plasma glucose amount, post-diet [mg/dL] GLU_post 114747 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:97	Bennett4	hormone quantification	various diets 2	plasma glucose to insulin ratio, baseline [ratio] GLU_INS_base 114791 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:99	Bennett4	hormone quantification	various diets 2	plasma glucose to insulin ratio, post-diet [ratio] GLU_INS_post 114793 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

CGDpheno1:50	CGDpheno1	metabolic panel	(none)	glucose (plasma GLU, 4h fast) [mg/dL] GLU 31850	inbred w/CC8	72	both	12wks	N=7	2009

CGDpheno3:1	CGDpheno3	metabolic panel	(none)	glucose (plasma GLU, 4h fast) [mg/dL] GLU 43901	CC diallel w/par	62	both	8wks	N=5	2012

Chesler2:7	Chesler2	metabolic panel	(none)	glucose (blood GLU, no fast) [mg/dL] GLU 43407	CC diallel w/par	47	both	7-15wks	N=2	2011

Chesler2:8	Chesler2	metabolic panel	(none)	glucose (blood GLU, 16h fast) [mg/dL] GLU_fast 43408	CC diallel w/par	47	both	7-15wks	N=3	2011

Chesler3:7	Chesler3	metabolic panel	(none)	glucose (blood GLU, no fast) [mg/dL] GLU 43507	CC pre w/par	190	both	7-15wks	N=1	2011

Chesler3:8	Chesler3	metabolic panel	(none)	glucose (blood GLU, 16h fast) [mg/dL] GLU_fast 43508	CC pre w/par	275	both	7-15wks	N=2	2011

Cheverud1:55	Cheverud1	glucose tolerance	high-fat diet	glucose levels, area under curve, glucose tolerance test (serum GLU, 10% glucose i.p., 4h fast) [AUC] GLU_clear10 17845 control diet high-fat diet	LGXSM w/par	18	both	10wks	N=8	2004

Cheverud1:57	Cheverud1	glucose tolerance	high-fat diet	glucose levels, area under curve, glucose tolerance test (serum GLU, 10% glucose i.p., 4h fast) [AUC] GLU_clear20 17846 control diet high-fat diet	LGXSM w/par	17	both	20wks	N=8	2004

Eumorphia1:6	Eumorphia1	metabolic panel	(none)	glucose (plasma GLU, ??h fast) [mg/dL] GLU 23906	inbred	6	both	12wks	N=29	2007

Eumorphia3:1	Eumorphia3	glucose tolerance	(none)	glucose levels during glucose tolerance test, age 12wks (20% glucose oral, 16h fast) [mg/dL] GLU_12wk 26411 minutes: 0 30 60 90 120 180	inbred	3	both	12wks	N=10	2008

Eumorphia3:7	Eumorphia3	glucose tolerance	(none)	glucose levels during glucose tolerance test, age 24wks (20% glucose oral, 16h fast) [mg/dL] GLU_24wk 26421 minutes: 0 30 60 90 120 180	inbred	4	both	24wks	N=8	2008

Eumorphia3:13	Eumorphia3	glucose tolerance	(none)	glucose levels during glucose tolerance test, age 52wks (20% glucose oral, 16h fast) [mg/dL] GLU_52wk 26431 minutes: 0 30 60 90 120 180	inbred	4	both	52wks	N=8	2008

GMC06:11	GMC06	metabolic panel	(none)	glucose (plasma GLU, 16h fast) [mmol/L] GLU 55511	inbred	5	both	10-11wks	N=16	2018

GMC11:3	GMC11	glucose tolerance	(none)	intraperitoneal glucose tolerance test (20% glucose i.p., 16h fast) [mmol/L] GLU 56011 glucose level at minute: 0 15 30 60 120	inbred	6	both	13-14wks	N=15	2018

GMC16:36	GMC16	metabolic panel	(none)	glucose (plasma GLU) [mmol/L] GLU 56536 age 16-17wks 20-21wks	inbred w/CC8	8	both		N=7	2018

HMDPpheno7:10	HMDPpheno7	metabolite quantification	(none)	liver glucose (16h fast), relative abundance glucose 50210	HMDP	106	m	16wks	N=1	2014

HMDPpheno7:23	HMDPpheno7	metabolite quantification	(none)	liver UDP-glucose (16h fast), relative abundance UDP_glucose 50223	HMDP	105	m	16wks	N=1	2014

JaxCC1:9151	JaxCC1	urinalysis	(none)	glucose (urine GLU) [mg/dL] urine_GLU 89151	CC	14	both	12-13wks	N=5	2017

JaxCC1:9191	JaxCC1	metabolic panel	(none)	glucose (plasma GLU, no fast) [mg/dL] GLU 89191	CC	18	both	17-19wks	N=6	2017

JaxKOMP-EAP:244	JaxKOMP-EAP	body weight	(none)	body weight (at time of glucose tolerance test) [g] bw_gtt body_weight_gtt 100575	KOMP	1512	both	12wks	N=8	2021

JaxKOMP-EAP:245	JaxKOMP-EAP	glucose tolerance	(none)	amount glucose injected glucose_injected amount_glucose_injected 100576	KOMP	1822	both	12wks	N=8	2021

JaxKOMP-EAP:246	JaxKOMP-EAP	glucose tolerance	(none)	plasma glucose time series plasma_glucose_gtt 100577 0min 15min 30min 60min 120min	KOMP	1825	both	12wks	N=8	2021

JaxKOMP-EAP:255	JaxKOMP-EAP	urinalysis	(none)	glucose (urine GLU) [mg/dL] urine_GLU glucose 100599	KOMP	307	both	13wks	N=9	2016

JaxKOMP-EAP:257	JaxKOMP-EAP	lipid profile	(none)	plasma glucose (4h fast) [mg/dL] glucose plasma_glucose 100686	KOMP	226	both	13wks	N=9	2014

JaxKOMP-EAP:384	JaxKOMP-EAP	metabolic panel	(none)	glucose (plasma GLU, no fast) [mg/dL] GLU glucose_glu 100158 IMPC_CBC_018_001	KOMP	1754	both	17wks	N=6	2021

JaxKOMP-LAP:227	JaxKOMP-LAP	body weight	(none)	body weight (at time of glucose tolerance test) [g] body_weight_gtt 101575	KOMP		both	70-76wks		2021

JaxKOMP-LAP:228	JaxKOMP-LAP	glucose tolerance	(none)	amount glucose injected amount_glucose_injected 101576	KOMP	121	both	70-76wks	N=7	2021

JaxKOMP-LAP:229	JaxKOMP-LAP	glucose tolerance	(none)	plasma glucose time series plasma_glucose_gtt 101577 0min 15min 30min 60min 120min	KOMP	121	both	70-76wks	N=7	2021

JaxKOMP-LAP:296	JaxKOMP-LAP	metabolic panel	(none)	glucose (plasma GLU, no fast) [mg/dL] GLU glucose_glu 101158 IMPC_CBC_018_001	KOMP	100	both	75-81wks	N=6	2021

Jaxpheno3:1	Jaxpheno3	metabolic panel	(none)	glucose (plasma GLU, 4h fast) [mg/dL] GLU 22801 age 8wks age 16wks	inbred	11	both		N=16	2006

Lake1:27	Lake1	metabolic panel	(none)	glucose (plasma GLU, 4h fast) [mg/dL] GLU 19927	B6.A consomic w/par	23	both	8wks	N=8	2005

Nadeau2:6	Nadeau2	metabolic panel	high-fat high-sucrose diet	glucose (blood GLU, 16h fast) [mmol/L] GLU 53021	B6.A consomic w/par	24	m	21wks	N=39	2015

Nadeau3:5	Nadeau3	metabolic panel	high-fat high-sucrose diet	blood glucose amount (overnight fast) after 16 wks on diet [mmol/L] GLU 114348 chow HFHS	inbred	2	m	21wks	N=17	2016

Naggert1:2	Naggert1	metabolic panel	high-fat diet	glucose (plasma GLU, 4h fast) [mg/dL] GLU 14302 baseline after 17wks on diet Δchange	inbred w/CC7	43	both	7-9wks	N=10	2003

Neuner1:11	Neuner1	metabolic panel	(none)	blood glucose level [mg/dL] glucose 65911 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Palmer3:51	Palmer3	metabolic panel	(none)	glucose (blood GLU, no fast) [mmol/L] glucose_base 59251	F1 Tcf7l2	30	both	7-14wks	N=5	2017

Palmer3:52	Palmer3	metabolic panel	(none)	glucose (blood GLU, 16h fast) [mmol/L] glucose_fast 59252	F1 Tcf7l2	30	both	7-14wks	N=5	2017

Palmer5:51	Palmer5	metabolic panel	(none)	glucose (blood GLU, no fast) [mmol/L] glucose_base 59751	F1 Tcf7l2	30	both	7-14wks	N=5	2017

Palmer5:52	Palmer5	metabolic panel	(none)	glucose (blood GLU, 16h fast) [mmol/L] glucose_fast 59752	F1 Tcf7l2	30	both	7-14wks	N=5	2017

RIKEN-EAD1:8	RIKEN-EAD1	metabolic panel	(none)	glucose (plasma GLU, 4h fast) [mg/dL] GLU 37208	inbred RBRC	37	both	8wks	N=10	2008

RIKEN-EAD2:8	RIKEN-EAD2	metabolic panel	(none)	glucose (plasma GLU, 4h fast) [mg/dL] GLU 37808	wild-derived RBRC	27	both	8wks	N=12	2008

Schonfeld1:1	Schonfeld1	metabolic panel	(none)	glucose (plasma GLU, no fast) [mg/dL] GLU 32301	inbred	11	both	9-13wks	N=6	2005

Schonfeld1:2	Schonfeld1	glucose tolerance	(none)	glucose levels during glucose tolerance test(10% glucose i.p., 5h fast) [mg/dL] GTT 32303 0 min 30 min 60 min 120 min	inbred	10	both	9-13wks	N=5	2005

Schonfeld1:6	Schonfeld1	glucose tolerance	(none)	glucose levels, area under curve, glucose tolerance test (10% glucose i.p., 5h fast) [AUC] AUC_GTT 32308 0 to 60 min 0 to 120 min	inbred	10	both	9-13wks	N=5	2005

Schonfeld1:8	Schonfeld1	hormone quantification	(none)	insulin level (plasma), 30 min post injection in glucose tolerance test (10% glucose i.p., 5h fast) [ng/mL] Insulin 32311	inbred	10	both	9-13wks	N=5	2005

Schonfeld1:9	Schonfeld1	insulin tolerance	(none)	glucose levels as percent of baseline, insulin tolerance test (human insulin 0.75 U/kg bw i.p., 5h fast) [%] pct_ITT 32313 0 min 30 min 60 min 120 min	inbred	10	both	9-13wks	N=5	2005

Schonfeld1:13	Schonfeld1	insulin tolerance	(none)	glucose levels, area under curve, insulin tolerance test (human insulin 0.75 U/kg bw i.p., 5h fast) [AUC] AUC_ITT 32318 0 to 60 min 0 to 120 min	inbred	10	both	9-13wks	N=5	2005

Schoonjans1:3	Schoonjans1	body weight	high-fat diet	body weight prior to glucose kinetic test, at 20 wks of age [g] bw_pre_gluc_kinetic 112634 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:5	Schoonjans1	body weight	high-fat diet	body weight after glucose kinetic test, at 20 wks of age [g] bw_post_gluc_kinetic 112636 CD HFD	BXD w/par	31	m	20wks	N=5	2021

Schoonjans1:9	Schoonjans1	glucose tolerance	high-fat diet	glucose, glucose kinetic test (Ensure Plus oral gavage, overday fast), at 20 wks of age, after 0 min [mmol/L] gluc_kinetic_t0 112640 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:11	Schoonjans1	glucose tolerance	high-fat diet	glucose, glucose kinetic test (Ensure Plus oral gavage, overday fast), at 20 wks of age, after 30 min [mmol/L] gluc_kinetic_t30 112642 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:13	Schoonjans1	glucose tolerance	high-fat diet	glucose, glucose kinetic test (Ensure Plus oral gavage, overday fast), at 20 wks of age, after 60 min [mmol/L] gluc_kinetic_t60 112644 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:15	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid 3-oxocholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] oxo_CA_plasma_t0 112646 CD HFD	BXD w/par	21	m	20wks	N=3	2021

Schoonjans1:17	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid 7-ketodeoxycholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] keto_DCA_plasma_t0 112648 CD HFD	BXD w/par	35	m	20wks	N=4	2021

Schoonjans1:19	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid α-muricholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] aMCA_plasma_t0 112650 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:21	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid β-muricholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] bMCA_plasma_t0 112652 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:23	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid cholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] CA_plasma_t0 112654 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:25	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid chenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] CDCA_plasma_t0 112656 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:27	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid deoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] DCA_plasma_t0 112658 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:29	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid glycocholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] GCA_plasma_t0 112660 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:31	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid γ-muricholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] MCA_plasma_t0 112662 CD HFD	BXD w/par	18	m	20wks	N=2	2021

Schoonjans1:33	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid tauro-α-muricholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TaMCA_plasma_t0 112664 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:35	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid tauro-β-muricholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TbMCA_plasma_t0 112666 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:37	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurocholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TCA_plasma_t0 112668 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:39	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurochenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TCDCA_plasma_t0 112670 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:41	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TDCA_plasma_t0 112672 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:43	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurohyodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] THDCA_plasma_t0 112674 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:45	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid tauroursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TUDCA_plasma_t0 112676 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:47	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid ursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] UDCA_plasma_t0 112678 CD HFD	BXD w/par	35	m	20wks	N=2	2021

Schoonjans1:49	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid ω-muricholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] wMCA_plasma_t0 112680 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:51	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid 3-oxocholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] oxo_CA_plasma_t30 112682 CD HFD	BXD w/par	17	m	20wks	N=2	2021

Schoonjans1:53	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid 7-ketodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] keto_DCA_plasma_t30 112684 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:55	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] aMCA_plasma_t30 112686 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:57	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid β-muricholic acid, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] bMCA_plasma_t30 112688 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:59	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid cholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] CA_plasma_t30 112690 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:61	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid chenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] CDCA_plasma_t30 112692 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:63	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid deoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] DCA_plasma_t30 112694 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:65	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid glycocholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] GCA_plasma_t30 112696 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:67	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid γ-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] MCA_plasma_t30 112698 CD HFD	BXD w/par	18	m	20wks	N=2	2021

Schoonjans1:69	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid tauro-α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TaMCA_plasma_t30 112700 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:71	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid tauro-β-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TbMCA_plasma_t30 112702 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:73	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurocholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TCA_plasma_t30 112704 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:75	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurochenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TCDCA_plasma_t30 112706 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:77	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TDCA_plasma_t30 112708 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:79	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurohyodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] THDCA_plasma_t30 112710 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:81	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid tauroursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TUDCA_plasma_t30 112712 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:83	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid ursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] UDCA_plasma_t30 112714 CD HFD	BXD w/par	33	m	20wks	N=2	2021

Schoonjans1:85	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid ω-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] wMCA_plasma_t30 112716 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:87	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid 3-oxocholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] oxo_CA_plasma_t60 112718 CD HFD	BXD w/par	19	m	20wks	N=2	2021

Schoonjans1:89	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid 7-ketodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] keto_DCA_plasma_t60 112720 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:91	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] aMCA_plasma_t60 112722 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:93	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid β-muricholic acid, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] bMCA_plasma_t60 112724 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:95	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid cholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] CA_plasma_t60 112726 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:97	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid chenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] CDCA_plasma_t60 112728 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:99	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid deoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] DCA_plasma_t60 112730 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:101	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid glycocholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] GCA_plasma_t60 112732 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:103	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid γ-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] MCA_plasma_t60 112734 CD HFD	BXD w/par	15	m	20wks	N=2	2021

Schoonjans1:105	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid tauro-α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TaMCA_plasma_t60 112736 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:107	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid tauro-β-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TbMCA_plasma_t60 112738 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:109	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurocholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TCA_plasma_t60 112740 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:111	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurochenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TCDCA_plasma_t60 112742 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Schoonjans1:113	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TDCA_plasma_t60 112744 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:115	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid taurohyodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] THDCA_plasma_t60 112746 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:117	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid tauroursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TUDCA_plasma_t60 112748 CD HFD	BXD w/par	36	m	20wks	N=4	2021

Schoonjans1:119	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid ursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] UDCA_plasma_t60 112750 CD HFD	BXD w/par	33	m	20wks	N=2	2021

Schoonjans1:121	Schoonjans1	biomarker quantification	high-fat diet	plasma bile acid ω-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] wMCA_plasma_t60 112752 CD HFD	BXD w/par	36	m	20wks	N=5	2021

Shockley1:5	Shockley1	metabolic panel	high-fat diet	glucose (serum GLU, 5h fast) [mg/dL] GLU 33405 control diet high-fat diet difference	inbred	10	both	10-13wks	N=5	2008

Svenson3:63	Svenson3	metabolic panel	(none)	glucose (plasma GLU, 4h fast) [mg/dL] GLU 27363	B6.PWD consomic w/par	27	both	8wks	N=7	2006

Xenakis2:216	Xenakis2	metabolic panel	arsenic	fasting blood glucose (6h fast) [mg/dL] FBG 118370 iAs: 1 wk before 4 wks after 8 wks after 13 wks after 16 wks after 20 wks after 25 wks after	DO population		m	7-33wks	N=74	2022

Xenakis2:223	Xenakis2	metabolic panel	arsenic	blood glucose, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection [mg/dL] BG15 118377 iAs: 1 wk before 13 wks after 25 wks after	DO population		m	7-33wks	N=74	2022

Xenakis2:233	Xenakis2	hormone quantification	arsenic	plasma insulin, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection [ng/mL] PI15 118387 iAs: 1 wk before 13 wks after 25 wks after	DO population		m	7-33wks	N=72	2022

Xenakis2:243	Xenakis2	hormone quantification	arsenic	plasma insulin, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection, coefficient of variation (CV) [%] PI15_CV 118397 iAs: 1wk before 13 wks after 25 wks after	DO population		m	7-33wks	N=72	2022

Attie2

None

(none)

date of oral glucose tolerance test date_oGTT 110628 categorical informational

DO population

both

N=248

2018

Attie2

metabolic panel

high-fat high-sucrose diet

plasma glucose after diet (4h fast) [mg/dL] GLU 110693 wk: 6 10 14 22

DO population

both

10-26wks

N=250

2018

Attie2

body weight

high-fat high-sucrose diet

body weight at time of oral glucose tolerance test (~14 wks on diet) [g] bw_oGTT 110705

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

glucose level at t=0 after ~14 wks on diet (4h fast) [mg/dL] GLU_0min 110706

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

insulin level at t=0 after ~14 wks on diet (4h fast) [ng/mL] INS_0min 110707

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

HOMA-IR: (glucose x insulin) / 405 at t=0 after ~14 wks on diet (4h fast) HOMA_IR 110708

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

HOMA-B: (360 x insulin) / (glucose minus 63) at t=0 after ~14 wks on diet (4h fast) HOMA_B 110709

DO population

both

18wks

N=246

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

glucose area under curve (AUC) after ~14 wks on diet without correction for baseline difference (4h fast) [AUC] GLU_AUC_tot 110710

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

glucose area under curve (AUC) after ~14 wks on diet after subtraction of glucose at t=0 (4h fast) [AUC] GLU_AUC_adj 110711

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

insulin area under curve (AUC) after ~14 wks on diet without correction for baseline difference (4h fast) [AUC] INS_AUC_tot 110712

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

insulin area under curve (AUC) after ~14 wks on diet after subtraction of insulin at t=0 (4h fast) [AUC] INS_AUC_adj 110713

DO population

both

18wks

N=248

2018

Attie2

hormone quantification

high-fat high-sucrose diet

plasma adiponectin measured at the time oral glucose tolerance test performed after ~14 wks on diet (4h fast) [µg/mL] adiponectin 110714

DO population

both

18wks

N=144

2018

Attie2

hormone quantification

high-fat high-sucrose diet

plasma leptin measured at the time oral glucose tolerance test performed after ~14 wks on diet (4h fast) [ng/mL] leptin 110715

DO population

both

18wks

N=96

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to glucose [ng/mL] INS_GLU 110719 3.3 mM 8.3 mM 16.7 mM

DO population

both

19-26wks

N=242

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl [ng/mL] INS_GLU3p3_KCl 110722

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1 [ng/mL] INS_GLU8p3_GLP1 110723

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu) [ng/mL] INS_GLU8p3_AA 110724

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid [ng/mL] INS_GLU16p7_PA 110725

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_fc_G3p3 110726

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose, expressed as fold-change over that observed with 3.3.mM glucose [ratio] INS_GLU16p7_fc_G3p3 110727

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU3p3__KCl_fc_G3p3 110728

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G3p3 110729

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G3p3 110730

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus palmitic acid, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU16p7_PA_fc_G3p3 110731

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G8p3 110732

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G8p3 110733

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as fold-change over that observed with 16.7 mM glucose [ratio] INS_GLU16p7_PA_fc_G16p7 110734

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to glucose, expressed as a percentage of total insulin per mouse [%] INS_pct_GLU 110735 3.3 mM 8.3 mM 16.7 mM

DO population

both

19-26wks

N=241

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as a percentage of total insulin per mouse [%] INS_GLU3p3_KCl_pct 110738

DO population

both

19-26wks

N=239

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as a percentage of total insulin per mouse [%] INS_GLU8p3_GLP1_pct 110739

DO population

both

19-26wks

N=239

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as a percentage of total insulin per mouse [%] INS_GLU8p3_AA_pct 110740

DO population

both

19-26wks

N=239

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as a percentage of total insulin per mouse [%] INS_GLU16p7_PA_pct 110741

DO population

both

19-26wks

N=239

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to glucose (geometric mean) [ng/mL] INS_gm_GLU 110742 3.3 mM 8.3 mM 16.7 mM

DO population

both

19-26wks

N=242

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl (geometric mean) [ng/mL] INS_gm_GLU3p3_KCl 110745

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1 (geometric mean) [ng/mL] INS_gm_GLU8p3_GLP1 110746

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu) (geometric mean) [ng/mL] INS_gm_GLU8p3_AA 110747

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid (geometric mean) [ng/mL] INS_gm_GLU16p7_PA 110748

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo glucagon secretion after diet in response to 3.3 mM glucose plus 40 mM KCl [ng/mL] GCG_GLU3p3_KCl 110750

DO population

both

19-26wks

N=182

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo glucagon secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as a percentage of total glucagon per mouse [%] GCG_GLU3p3_KCl_pct 110751

DO population

both

19-26wks

N=182

2018

Auwerx1

body weight

high-fat diet

body weight prior to oral glucose tolerance test (OGTT), 17 wks of age [g] bw_ogtt 111242 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose baseline, glucose tolerance test (pregavage, overnight fast) [mg/dL] ogtt_gluc_t0 111244 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [mg/dL] ogtt_gluc_t15 111246 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [mg/dL] ogtt_gluc_t30 111248 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 45 min [mg/dL] ogtt_gluc_t45 111250 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 60 min [mg/dL] ogtt_gluc_t60 111252 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 90 min [mg/dL] ogtt_gluc_t90 111254 CD HFD

BXD w/par

55

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 120 min [mg/dL] ogtt_gluc_t120 111256 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 150 min [mg/dL] ogtt_gluc_t150 111258 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 180 min [mg/dL] ogtt_gluc_t180 111260 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, area under curve, glucose tolerance test (20% glucose oral gavage, overnight fast) [AUC] ogtt_gluc_auc 111262 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

hormone quantification

high-fat diet

insulin baseline, glucose tolerance test (pregavage, overnight fast) [µg/L] ogtt_ins_t0 111264 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

hormone quantification

high-fat diet

insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [µg/L] ogtt_ins_t15 111266 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

hormone quantification

high-fat diet

insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [µg/L] ogtt_ins_t30 111268 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

hormone quantification

high-fat diet

insulin, area under curve, glucose tolerance test (20% glucose oral gavage, overnight fast) [AUC] ogtt_ins_auc 111270 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

blood glucose amount [mmol/L] glu 111356 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx2

body weight

(none)

body weight loss following 16h fast, prior to oral glucose tolerance test (OGTT), 16 wks of age [g] bw_16wks_ogtt 114581 CD HFD

inbred w/CC8

9

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose baseline, glucose tolerance test (pregavage, overnight fast) [mg/dL] ogtt_gluc_t0 114583 CD HFD

inbred w/CC8

9

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [mg/dL] ogtt_gluc_t15 114585 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [mg/dL] ogtt_gluc_t30 114587 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 45 min [mg/dL] ogtt_gluc_t45 114589 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 60 min [mg/dL] ogtt_gluc_t60 114591 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 90 min [mg/dL] ogtt_gluc_t90 114593 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 120 min [mg/dL] ogtt_gluc_t120 114595 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 150 min [mg/dL] ogtt_gluc_t150 114597 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

glucose tolerance

(none)

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 180 min [mg/dL] ogtt_gluc_t180 114599 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

hormone quantification

(none)

insulin baseline, glucose tolerance test (pregavage, overnight fast) [µg/L] ogtt_ins_t0 114601 CD HFD

inbred w/CC8

9

both

16wks

N=4

2021

Auwerx2

hormone quantification

(none)

insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [µg/L] ogtt_ins_t15 114603 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Auwerx2

hormone quantification

(none)

insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [µg/L] ogtt_ins_t30 114605 CD HFD

inbred w/CC8

8

both

16wks

N=4

2021

Bennett4

metabolic panel

various diets 2

plasma glucose amount, baseline [mg/dL] GLU_base 114745 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

metabolic panel

various diets 2

plasma glucose amount, post-diet [mg/dL] GLU_post 114747 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

hormone quantification

various diets 2

plasma glucose to insulin ratio, baseline [ratio] GLU_INS_base 114791 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

hormone quantification

various diets 2

plasma glucose to insulin ratio, post-diet [ratio] GLU_INS_post 114793 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

CGDpheno1

metabolic panel

(none)

glucose (plasma GLU, 4h fast) [mg/dL] GLU 31850

inbred w/CC8

72

both

12wks

N=7

2009

CGDpheno3

metabolic panel

(none)

glucose (plasma GLU, 4h fast) [mg/dL] GLU 43901

CC diallel w/par

62

both

8wks

N=5

2012

Chesler2

metabolic panel

(none)

glucose (blood GLU, no fast) [mg/dL] GLU 43407

CC diallel w/par

47

both

7-15wks

N=2

2011

Chesler2

metabolic panel

(none)

glucose (blood GLU, 16h fast) [mg/dL] GLU_fast 43408

CC diallel w/par

47

both

7-15wks

N=3

2011

Chesler3

metabolic panel

(none)

glucose (blood GLU, no fast) [mg/dL] GLU 43507

CC pre w/par

190

both

7-15wks

N=1

2011

Chesler3

metabolic panel

(none)

glucose (blood GLU, 16h fast) [mg/dL] GLU_fast 43508

CC pre w/par

275

both

7-15wks

N=2

2011

Cheverud1

glucose tolerance

high-fat diet

glucose levels, area under curve, glucose tolerance test (serum GLU, 10% glucose i.p., 4h fast) [AUC] GLU_clear10 17845 control diet high-fat diet

LGXSM w/par

18

both

10wks

N=8

2004

Cheverud1

glucose tolerance

high-fat diet

glucose levels, area under curve, glucose tolerance test (serum GLU, 10% glucose i.p., 4h fast) [AUC] GLU_clear20 17846 control diet high-fat diet

LGXSM w/par

17

both

20wks

N=8

2004

Eumorphia1

metabolic panel

(none)

glucose (plasma GLU, ??h fast) [mg/dL] GLU 23906

inbred

6

both

12wks

N=29

2007

Eumorphia3

glucose tolerance

(none)

glucose levels during glucose tolerance test, age 12wks (20% glucose oral, 16h fast) [mg/dL] GLU_12wk 26411 minutes: 0 30 60 90 120 180

inbred

3

both

12wks

N=10

2008

Eumorphia3

glucose tolerance

(none)

glucose levels during glucose tolerance test, age 24wks (20% glucose oral, 16h fast) [mg/dL] GLU_24wk 26421 minutes: 0 30 60 90 120 180

inbred

4

both

24wks

N=8

2008

Eumorphia3

glucose tolerance

(none)

glucose levels during glucose tolerance test, age 52wks (20% glucose oral, 16h fast) [mg/dL] GLU_52wk 26431 minutes: 0 30 60 90 120 180

inbred

4

both

52wks

N=8

2008

GMC06

metabolic panel

(none)

glucose (plasma GLU, 16h fast) [mmol/L] GLU 55511

inbred

5

both

10-11wks

N=16

2018

GMC11

glucose tolerance

(none)

intraperitoneal glucose tolerance test (20% glucose i.p., 16h fast) [mmol/L] GLU 56011 glucose level at minute: 0 15 30 60 120

inbred

6

both

13-14wks

N=15

2018

GMC16

metabolic panel

(none)

glucose (plasma GLU) [mmol/L] GLU 56536 age 16-17wks 20-21wks

inbred w/CC8

8

both

N=7

2018

HMDPpheno7

metabolite quantification

(none)

liver glucose (16h fast), relative abundance glucose 50210

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver UDP-glucose (16h fast), relative abundance UDP_glucose 50223

HMDP

105

m

16wks

N=1

2014

JaxCC1

urinalysis

(none)

glucose (urine GLU) [mg/dL] urine_GLU 89151

CC

14

both

12-13wks

N=5

2017

JaxCC1

metabolic panel

(none)

glucose (plasma GLU, no fast) [mg/dL] GLU 89191

CC

18

both

17-19wks

N=6

2017

JaxKOMP-EAP

body weight

(none)

body weight (at time of glucose tolerance test) [g] bw_gtt body_weight_gtt 100575

KOMP

1512

both

12wks

N=8

2021

JaxKOMP-EAP

glucose tolerance

(none)

amount glucose injected glucose_injected amount_glucose_injected 100576

KOMP

1822

both

12wks

N=8

2021

JaxKOMP-EAP

glucose tolerance

(none)

plasma glucose time series plasma_glucose_gtt 100577 0min 15min 30min 60min 120min

KOMP

1825

both

12wks

N=8

2021

JaxKOMP-EAP

urinalysis

(none)

glucose (urine GLU) [mg/dL] urine_GLU glucose 100599

KOMP

307

both

13wks

N=9

2016

JaxKOMP-EAP

lipid profile

(none)

plasma glucose (4h fast) [mg/dL] glucose plasma_glucose 100686

KOMP

226

both

13wks

N=9

2014

JaxKOMP-EAP

metabolic panel

(none)

glucose (plasma GLU, no fast) [mg/dL] GLU glucose_glu 100158 IMPC_CBC_018_001

KOMP

1754

both

17wks

N=6

2021

JaxKOMP-LAP

body weight

(none)

body weight (at time of glucose tolerance test) [g] body_weight_gtt 101575

KOMP

both

70-76wks

2021

JaxKOMP-LAP

glucose tolerance

(none)

amount glucose injected amount_glucose_injected 101576

KOMP

121

both

70-76wks

N=7

2021

JaxKOMP-LAP

glucose tolerance

(none)

plasma glucose time series plasma_glucose_gtt 101577 0min 15min 30min 60min 120min

KOMP

121

both

70-76wks

N=7

2021

JaxKOMP-LAP

metabolic panel

(none)

glucose (plasma GLU, no fast) [mg/dL] GLU glucose_glu 101158 IMPC_CBC_018_001

KOMP

100

both

75-81wks

N=6

2021

Jaxpheno3

metabolic panel

(none)

glucose (plasma GLU, 4h fast) [mg/dL] GLU 22801 age 8wks age 16wks

inbred

11

both

N=16

2006

Lake1

metabolic panel

(none)

glucose (plasma GLU, 4h fast) [mg/dL] GLU 19927

B6.A consomic w/par

23

both

8wks

N=8

2005

Nadeau2

metabolic panel

high-fat high-sucrose diet

glucose (blood GLU, 16h fast) [mmol/L] GLU 53021

B6.A consomic w/par

24

m

21wks

N=39

2015

Nadeau3

metabolic panel

high-fat high-sucrose diet

blood glucose amount (overnight fast) after 16 wks on diet [mmol/L] GLU 114348 chow HFHS

inbred

2

m

21wks

N=17

2016

Naggert1

metabolic panel

high-fat diet

glucose (plasma GLU, 4h fast) [mg/dL] GLU 14302 baseline after 17wks on diet Δchange

inbred w/CC7

43

both

7-9wks

N=10

2003

Neuner1

metabolic panel

(none)

blood glucose level [mg/dL] glucose 65911 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=6

2019

Palmer3

metabolic panel

(none)

glucose (blood GLU, no fast) [mmol/L] glucose_base 59251

F1 Tcf7l2

30

both

7-14wks

N=5

2017

Palmer3

metabolic panel

(none)

glucose (blood GLU, 16h fast) [mmol/L] glucose_fast 59252

F1 Tcf7l2

30

both

7-14wks

N=5

2017

Palmer5

metabolic panel

(none)

glucose (blood GLU, no fast) [mmol/L] glucose_base 59751

F1 Tcf7l2

30

both

7-14wks

N=5

2017

Palmer5

metabolic panel

(none)

glucose (blood GLU, 16h fast) [mmol/L] glucose_fast 59752

F1 Tcf7l2

30

both

7-14wks

N=5

2017

RIKEN-EAD1

metabolic panel

(none)

glucose (plasma GLU, 4h fast) [mg/dL] GLU 37208

inbred RBRC

37

both

8wks

N=10

2008

RIKEN-EAD2

metabolic panel

(none)

glucose (plasma GLU, 4h fast) [mg/dL] GLU 37808

wild-derived RBRC

27

both

8wks

N=12

2008

Schonfeld1

metabolic panel

(none)

glucose (plasma GLU, no fast) [mg/dL] GLU 32301

inbred

11

both

9-13wks

N=6

2005

Schonfeld1

glucose tolerance

(none)

glucose levels during glucose tolerance test(10% glucose i.p., 5h fast) [mg/dL] GTT 32303 0 min 30 min 60 min 120 min

inbred

10

both

9-13wks

N=5

2005

Schonfeld1

glucose tolerance

(none)

glucose levels, area under curve, glucose tolerance test (10% glucose i.p., 5h fast) [AUC] AUC_GTT 32308 0 to 60 min 0 to 120 min

inbred

10

both

9-13wks

N=5

2005

Schonfeld1

hormone quantification

(none)

insulin level (plasma), 30 min post injection in glucose tolerance test (10% glucose i.p., 5h fast) [ng/mL] Insulin 32311

inbred

10

both

9-13wks

N=5

2005

Schonfeld1

insulin tolerance

(none)

glucose levels as percent of baseline, insulin tolerance test (human insulin 0.75 U/kg bw i.p., 5h fast) [%] pct_ITT 32313 0 min 30 min 60 min 120 min

inbred

10

both

9-13wks

N=5

2005

Schonfeld1

insulin tolerance

(none)

glucose levels, area under curve, insulin tolerance test (human insulin 0.75 U/kg bw i.p., 5h fast) [AUC] AUC_ITT 32318 0 to 60 min 0 to 120 min

inbred

10

both

9-13wks

N=5

2005

Schoonjans1

body weight

high-fat diet

body weight prior to glucose kinetic test, at 20 wks of age [g] bw_pre_gluc_kinetic 112634 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

body weight

high-fat diet

body weight after glucose kinetic test, at 20 wks of age [g] bw_post_gluc_kinetic 112636 CD HFD

BXD w/par

31

m

20wks

N=5

2021

Schoonjans1

glucose tolerance

high-fat diet

glucose, glucose kinetic test (Ensure Plus oral gavage, overday fast), at 20 wks of age, after 0 min [mmol/L] gluc_kinetic_t0 112640 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

glucose tolerance

high-fat diet

glucose, glucose kinetic test (Ensure Plus oral gavage, overday fast), at 20 wks of age, after 30 min [mmol/L] gluc_kinetic_t30 112642 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

glucose tolerance

high-fat diet

glucose, glucose kinetic test (Ensure Plus oral gavage, overday fast), at 20 wks of age, after 60 min [mmol/L] gluc_kinetic_t60 112644 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 3-oxocholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] oxo_CA_plasma_t0 112646 CD HFD

BXD w/par

21

m

20wks

N=3

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 7-ketodeoxycholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] keto_DCA_plasma_t0 112648 CD HFD

BXD w/par

35

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid α-muricholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] aMCA_plasma_t0 112650 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid β-muricholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] bMCA_plasma_t0 112652 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid cholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] CA_plasma_t0 112654 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid chenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] CDCA_plasma_t0 112656 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid deoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] DCA_plasma_t0 112658 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid glycocholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] GCA_plasma_t0 112660 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid γ-muricholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] MCA_plasma_t0 112662 CD HFD

BXD w/par

18

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-α-muricholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TaMCA_plasma_t0 112664 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-β-muricholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TbMCA_plasma_t0 112666 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurocholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TCA_plasma_t0 112668 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurochenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TCDCA_plasma_t0 112670 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TDCA_plasma_t0 112672 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurohyodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] THDCA_plasma_t0 112674 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauroursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TUDCA_plasma_t0 112676 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] UDCA_plasma_t0 112678 CD HFD

BXD w/par

35

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ω-muricholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] wMCA_plasma_t0 112680 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 3-oxocholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] oxo_CA_plasma_t30 112682 CD HFD

BXD w/par

17

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 7-ketodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] keto_DCA_plasma_t30 112684 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] aMCA_plasma_t30 112686 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid β-muricholic acid, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] bMCA_plasma_t30 112688 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid cholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] CA_plasma_t30 112690 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid chenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] CDCA_plasma_t30 112692 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid deoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] DCA_plasma_t30 112694 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid glycocholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] GCA_plasma_t30 112696 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid γ-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] MCA_plasma_t30 112698 CD HFD

BXD w/par

18

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TaMCA_plasma_t30 112700 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-β-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TbMCA_plasma_t30 112702 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurocholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TCA_plasma_t30 112704 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurochenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TCDCA_plasma_t30 112706 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TDCA_plasma_t30 112708 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurohyodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] THDCA_plasma_t30 112710 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauroursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TUDCA_plasma_t30 112712 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] UDCA_plasma_t30 112714 CD HFD

BXD w/par

33

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ω-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] wMCA_plasma_t30 112716 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 3-oxocholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] oxo_CA_plasma_t60 112718 CD HFD

BXD w/par

19

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 7-ketodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] keto_DCA_plasma_t60 112720 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] aMCA_plasma_t60 112722 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid β-muricholic acid, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] bMCA_plasma_t60 112724 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid cholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] CA_plasma_t60 112726 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid chenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] CDCA_plasma_t60 112728 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid deoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] DCA_plasma_t60 112730 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid glycocholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] GCA_plasma_t60 112732 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid γ-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] MCA_plasma_t60 112734 CD HFD

BXD w/par

15

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TaMCA_plasma_t60 112736 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-β-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TbMCA_plasma_t60 112738 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurocholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TCA_plasma_t60 112740 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurochenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TCDCA_plasma_t60 112742 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TDCA_plasma_t60 112744 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurohyodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] THDCA_plasma_t60 112746 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauroursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TUDCA_plasma_t60 112748 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] UDCA_plasma_t60 112750 CD HFD

BXD w/par

33

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ω-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] wMCA_plasma_t60 112752 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Shockley1

metabolic panel

high-fat diet

glucose (serum GLU, 5h fast) [mg/dL] GLU 33405 control diet high-fat diet difference

inbred

10

both

10-13wks

N=5

2008

Svenson3

metabolic panel

(none)

glucose (plasma GLU, 4h fast) [mg/dL] GLU 27363

B6.PWD consomic w/par

27

both

8wks

N=7

2006

Xenakis2

metabolic panel

arsenic

fasting blood glucose (6h fast) [mg/dL] FBG 118370 iAs: 1 wk before 4 wks after 8 wks after 13 wks after 16 wks after 20 wks after 25 wks after

DO population

m

7-33wks

N=74

2022

Xenakis2

metabolic panel

arsenic

blood glucose, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection [mg/dL] BG15 118377 iAs: 1 wk before 13 wks after 25 wks after

DO population

m

7-33wks

N=74

2022

Xenakis2

hormone quantification

arsenic

plasma insulin, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection [ng/mL] PI15 118387 iAs: 1 wk before 13 wks after 25 wks after

DO population

m

7-33wks

N=72

2022

Xenakis2

hormone quantification

arsenic

plasma insulin, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection, coefficient of variation (CV) [%] PI15_CV 118397 iAs: 1wk before 13 wks after 25 wks after

DO population

m

7-33wks

N=72

2022

Filter Table Results